Y Mishima Selected Research

Y Mishima Research Topics

Disease

9	Neoplasms (Cancer) 11/2017 - 01/2000
4	Melanoma (Melanoma, Malignant) 09/2003 - 01/2000
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2017 - 11/2008
3	Multiple Myeloma 09/2014 - 12/2013
2	Lymphoma (Lymphomas) 04/2011 - 08/2007
2	Colitis 11/2010 - 02/2010
2	Inflammation (Inflammations) 11/2010 - 02/2010
2	Neoplasm Metastasis (Metastasis) 06/2010 - 01/2000
2	Leukemia 06/2001 - 11/2000
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2017
1	Hematologic Neoplasms (Hematological Malignancy) 01/2016
1	Bone Diseases (Bone Disease) 09/2014
1	Neutropenia 10/2012
1	Transfusion-Related Acute Lung Injury 10/2012
1	Transfusion Reaction 10/2012
1	Necrosis 11/2010
1	Pleural Effusion (Pleural Effusions) 06/2010
1	Carcinoma (Carcinomatosis) 06/2010
1	Insulin Resistance 05/2001
1	Type 2 Diabetes Mellitus (MODY) 05/2001
1	Obesity 05/2001
1	Myeloid Leukemia (Leukemia, Myelocytic) 11/2000
1	Infections 10/2000
1	Amelanotic Melanoma (Amelanotic Melanomas) 06/2000
1	Colorectal Neoplasms (Colorectal Cancer) 01/2000
1	Hepatoblastoma 01/2000
1	Hyperpigmentation 01/2000

Drug/Important Bio-Agent (IBA)

4	Rituximab (Mabthera)FDA Link 01/2017 - 11/2008
4	Melanins (Melanin)IBA 10/2000 - 01/2000
2	Messenger RNA (mRNA)IBA 11/2017 - 05/2001
2	Proteins (Proteins, Gene)FDA Link 11/2017 - 11/2000
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2017 - 03/2009
2	Interleukin-2 Receptors (IL 2 Receptor)IBA 01/2017 - 03/2009
2	Vincristine (Oncovin)FDA LinkGeneric 01/2017 - 03/2009
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017 - 03/2009
2	RNA (Ribonucleic Acid)IBA 01/2017 - 01/2016
2	Prednisone (Sone)FDA LinkGeneric 01/2017 - 03/2009
2	Dextrans (Dextran)FDA Link 11/2010 - 02/2010
2	SodiumIBA 11/2010 - 02/2010
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2001 - 05/2001
2	4-boronophenylalanineIBA 06/2000 - 04/2000
2	BoronIBA 06/2000 - 04/2000
2	Monophenol Monooxygenase (Tyrosinase)IBA 06/2000 - 01/2000
1	locked nucleic acidIBA 01/2017
1	erucylphosphocholineIBA 01/2016
1	spebrutinibIBA 09/2014
1	carfilzomibIBA 09/2014
1	Agammaglobulinaemia Tyrosine KinaseIBA 09/2014
1	Proteasome InhibitorsIBA 09/2014
1	Protein Isoforms (Isoforms)IBA 04/2014
1	Phosphotransferases (Kinase)IBA 12/2013
1	RGB 286638IBA 12/2013
1	AntigensIBA 10/2012
1	LipopolysaccharidesIBA 11/2010
1	Immunoglobulins (Immunoglobulin)IBA 11/2010
1	AcidsIBA 11/2010
1	Serum AlbuminIBA 06/2010
1	Toll-Like Receptor 5IBA 02/2010
1	FlagellinIBA 02/2010
1	Biomarkers (Surrogate Marker)IBA 11/2008
1	DNA (Deoxyribonucleic Acid)IBA 08/2007
1	AntibodiesIBA 06/2001
1	Caspase 3 (Caspase-3)IBA 06/2001
1	NF-kappa B (NF-kB)IBA 06/2001
1	Insulin (Novolin)FDA Link 05/2001
1	Complement Factor B (Factor B)IBA 11/2000
1	Apoptosis Inducing FactorIBA 11/2000
1	Amino Acids FDA Link 04/2000
1	Tyrosine (L-Tyrosine)FDA Link 04/2000
1	FructoseIBA 04/2000
1	Carcinoembryonic AntigenIBA 01/2000
1	DichlorvosIBA 01/2000

Therapy/Procedure

5	Therapeutics 01/2017 - 06/2001
4	Boron Neutron Capture Therapy 09/2003 - 01/2000
1	Drug Therapy (Chemotherapy) 06/2010
1	Combination Drug Therapy (Combination Chemotherapy) 11/2008
1	Intraperitoneal Injections 04/2000